AUY922 Effectively Overcomes MET- and AXL-Mediated Resistance to EGFR-TKI in Lung Cancer Cells

Yun Jung Choi(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Chang‐Min Choi(Ulsan College)
PLoS ONE
March 17, 2015
10.1371/journal.pone.0119832
Cited by 25

Related Papers

Cyr61 synthesis is induced by interleukin-6 and promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis
|Arthritis Research & Therapy|2020|49
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
|Nature Cancer|2023|46
Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors
|PLoS ONE|2013|11
The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02–011 Overcomes C797S-Mediated Resistance in Lung Cancer
|Cancer Research|2022|5